ACADIA Pharmaceuticals (NASDAQ:ACAD) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.06 by 83.33 percent. This is a 10 percent increase over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $244.32 million which beat the analyst consensus estimate of $239.34 million by 2.08 percent. This is a 18.70 percent increase over sales of $205.83 million the same period last year.